Bank Of America Corp Vaxcyte, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 569,890 shares of PCVX stock, worth $46.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

569,890

Previous 471,281 20.92%

Holding current value

$46.7 Million

Previous $35.6 Million 82.84%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $6.95 Million - $11.5 Million	98,609 Added 20.92%	569,890 $65.1 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $11.1 Million - $14.6 Million	185,405 Added 64.86%	471,281 $35.6 Million
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $6.68 Million - $9.06 Million	111,725 Added 64.15%	285,876 $19.5 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $3.04 Million - $4.25 Million	-66,952 Reduced 27.77%	174,151 $10.9 Million
Q2 2023 Aug 14, 2023	SELL	$34.66 - $54.07 $1.49 Million - $2.33 Million	-43,006 Reduced 15.14%	241,103 $12 Million
Q1 2023 May 12, 2023	SELL	$36.27 - $47.2 $453,737 - $590,472	-12,510 Reduced 4.22%	284,109 $10.6 Million
Q4 2022 Feb 10, 2023	BUY	$20.58 - $47.95 $3.91 Million - $9.12 Million	190,164 Added 178.63%	296,619 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $220,175 - $289,608	10,151 Added 10.54%	106,455 $2.56 Million
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $1.02 Million - $1.54 Million	57,826 Added 150.28%	96,304 $2.1 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $638,843 - $964,486	-36,589 Reduced 48.74%	38,478 $929,000
Q4 2021 Feb 08, 2022	BUY	$19.32 - $26.45 $904,832 - $1.24 Million	46,834 Added 165.88%	75,067 $1.79 Million
Q3 2021 Nov 15, 2021	SELL	$20.26 - $26.97 $1.02 Million - $1.36 Million	-50,378 Reduced 64.09%	28,233 $716,000
Q2 2021 Sep 13, 2021	BUY	$16.45 - $24.06 $1.29 Million - $1.89 Million	78,611 New	78,611 $1.77 Million

Others Institutions Holding PCVX

# of Institutions

353

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.86B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Vaxcyte, Inc. Transaction History